115 related articles for article (PubMed ID: 21076048)
1. B1, a novel amonafide analogue, overcomes the resistance conferred by Bcl-2 in human promyelocytic leukemia HL60 cells.
Liang X; Xu Y; Xu K; Liu J; Qian X
Mol Cancer Res; 2010 Dec; 8(12):1619-32. PubMed ID: 21076048
[TBL] [Abstract][Full Text] [Related]
2. M(2)-A induces apoptosis and G(2)-M arrest via inhibiting PI3K/Akt pathway in HL60 cells.
Wang J; Wu A; Xu Y; Liu J; Qian X
Cancer Lett; 2009 Oct; 283(2):193-202. PubMed ID: 19435648
[TBL] [Abstract][Full Text] [Related]
3. Induction of apoptosis and suppression of ERCC1 expression by the potent amonafide analogue 8-c in human colorectal carcinoma cells.
Wang Z; Liang X; Cheng Z; Xu Y; Yin P; Zhu H; Li Q; Qian X; Liu J
Anticancer Drugs; 2013 Apr; 24(4):355-65. PubMed ID: 23426174
[TBL] [Abstract][Full Text] [Related]
4. SAHA treatment overcomes the anti-apoptotic effects of Bcl-2 and is associated with the formation of mature PML nuclear bodies in human leukemic U937 cells.
Lee JS; Jeong SH; Soung YH; Kim TH; Choi HJ; Park BS; Kwon TK; Yoo YH
Chem Biol Interact; 2009 Sep; 181(1):61-70. PubMed ID: 19631782
[TBL] [Abstract][Full Text] [Related]
5. A novel resveratrol derivative, HS1793, overcomes the resistance conferred by Bcl-2 in human leukemic U937 cells.
Jeong SH; Jo WS; Song S; Suh H; Seol SY; Leem SH; Kwon TK; Yoo YH
Biochem Pharmacol; 2009 Apr; 77(8):1337-47. PubMed ID: 19426672
[TBL] [Abstract][Full Text] [Related]
6. A novel resveratrol analogue HS-1793 treatment overcomes the resistance conferred by Bcl-2 and is associated with the formation of mature PML nuclear bodies in renal clear cell carcinoma Caki-1 cells.
Jeong SH; Lee JS; Jeong NY; Kim TH; Yoo KS; Song S; Suh H; Kwon TK; Park BS; Yoo YH
Int J Oncol; 2009 Dec; 35(6):1353-60. PubMed ID: 19885558
[TBL] [Abstract][Full Text] [Related]
7. [Apoptosis and regulation of expressions of apoptosis-related gene Bcl-2 and p53 induced by selenium dioxide in three leukemia cell lines].
Wang XH; Wei YM; Bai H; Ou JF; Lu JH; Zheng RL
Di Yi Jun Yi Da Xue Xue Bao; 2004 Oct; 24(10):1160-3. PubMed ID: 15485790
[TBL] [Abstract][Full Text] [Related]
8. B1-induced caspase-independent apoptosis in MCF-7 cells is mediated by down-regulation of Bcl-2 via p53 binding to P2 promoter TATA box.
Liang X; Xu K; Xu Y; Liu J; Qian X
Toxicol Appl Pharmacol; 2011 Oct; 256(1):52-61. PubMed ID: 21821060
[TBL] [Abstract][Full Text] [Related]
9. Non-receptor tyrosine kinase Etk regulation of drug resistance in small-cell lung cancer.
Guo L; Zhou Y; Sun Y; Zhang F
Eur J Cancer; 2010 Feb; 46(3):636-41. PubMed ID: 20004564
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Bcl-2 expression by HuR in HL60 leukemia cells and A431 carcinoma cells.
Ishimaru D; Ramalingam S; Sengupta TK; Bandyopadhyay S; Dellis S; Tholanikunnel BG; Fernandes DJ; Spicer EK
Mol Cancer Res; 2009 Aug; 7(8):1354-66. PubMed ID: 19671677
[TBL] [Abstract][Full Text] [Related]
11. Bcl-2 expression and apoptosis induction in human HL60 leukaemic cells treated with a novel organotellurium(IV) compound RT-04.
Abondanza TS; Oliveira CR; Barbosa CM; Pereira FE; Cunha RL; Caires AC; Comasseto JV; Queiroz ML; Valadares MC; Bincoletto C
Food Chem Toxicol; 2008 Jul; 46(7):2540-5. PubMed ID: 18495315
[TBL] [Abstract][Full Text] [Related]
12. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M
Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347
[TBL] [Abstract][Full Text] [Related]
13. [Studies on programmed cell death induced by amsacrine and expression of bcl-2 in leukemia cell lines].
Wan Y; Wu D
Zhonghua Zhong Liu Za Zhi; 1997 Sep; 19(5):346-9. PubMed ID: 10920913
[TBL] [Abstract][Full Text] [Related]
14. Selective induction of apoptosis by the pyrrolo-1,5-benzoxazepine 7-[[dimethylcarbamoyl]oxy]-6-(2-naphthyl)pyrrolo-[2,1-d] (1,5)-benzoxazepine (PBOX-6) in Leukemia cells occurs via the c-Jun NH2-terminal kinase-dependent phosphorylation and inactivation of Bcl-2 and Bcl-XL.
Mc Gee MM; Greene LM; Ledwidge S; Campiani G; Nacci V; Lawler M; Williams DC; Zisterer DM
J Pharmacol Exp Ther; 2004 Sep; 310(3):1084-95. PubMed ID: 15143129
[TBL] [Abstract][Full Text] [Related]
15. Novel gene P28GANK confers multidrug resistance by modulating the expression of MDR-1, Bcl-2 and Bax in osteosarcoma cells.
Wang G; Rong J; Zhou Z; Duo J
Mol Biol (Mosk); 2010; 44(6):1010-7. PubMed ID: 21287809
[TBL] [Abstract][Full Text] [Related]
16. Evidence against a direct role for the induction of c-jun expression in the mediation of drug-induced apoptosis in human acute leukemia cells.
Bullock G; Ray S; Reed J; Miyashita T; Maria Ibrado A; Huang Y; Bhalla K
Clin Cancer Res; 1995 May; 1(5):559-64. PubMed ID: 9816016
[TBL] [Abstract][Full Text] [Related]
17. Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug.
Beh CW; Seow WY; Wang Y; Zhang Y; Ong ZY; Ee PL; Yang YY
Biomacromolecules; 2009 Jan; 10(1):41-8. PubMed ID: 19072631
[TBL] [Abstract][Full Text] [Related]
18. Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro.
Bai J; Sui J; Demirjian A; Vollmer CM; Marasco W; Callery MP
Cancer Res; 2005 Mar; 65(6):2344-52. PubMed ID: 15781649
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of BP1, a homeobox gene, is associated with resistance to all-trans retinoic acid in acute promyelocytic leukemia cells.
Awwad RT; Do K; Stevenson H; Fu SW; Lo-Coco F; Costello M; Campbell CL; Berg PE
Ann Hematol; 2008 Mar; 87(3):195-203. PubMed ID: 18026954
[TBL] [Abstract][Full Text] [Related]
20. GCS induces multidrug resistance by regulating apoptosis-related genes in K562/AO2 cell line.
Liu Y; Xie KM; Yang GQ; Bai XM; Shi YP; Mu HJ; Qiao WZ; Zhang B; Xie P
Cancer Chemother Pharmacol; 2010 Aug; 66(3):433-9. PubMed ID: 19936984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
